This news has been received from: CBS News

All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.

Johnson & Johnson expects to fall far short of its commitment to deliver 10 million doses of its COVID-19 vaccine by the end of February, with under 4 million to be ready to ship after a hoped-for emergency use authorization from the Food and Drug Administration. 

The disclosure of the shortfall by Johnson & Johnson is the first public measure of exactly how far the drug company has fallen behind its production goals.

Johnson & Johnson promised to deliver another 25 million by the end of March.

"We will have 20 million doses of the vaccine to be made available by the end of March and we're prepared to ship, immediately upon emergency use authorization, nearly 4 million doses of our vaccine," Dr. Richard Nettles, Johnson & Johnson subsidiary Janssen's vice president of medical affairs, told a House Energy & Commerce Committee hearing Tuesday. 

He said the company remains "confident in our plans to deliver 100 million" doses by the end of June.

As a single-dose vaccine that can be stored at standard refrigerator temperatures for three months, Johnson & Johnson's candidate had been heralded as a key advance in the U.S. vaccine effort despite its slightly lower efficacy, compared to two-dose vaccines produced by Pfizer and Moderna.

"It's a very easy vaccine to ship and administer; it doesn't have all of these complicated requirements, particularly like Pfizer, which is a much more delicate vaccine. A single dose, you get it, you're done. This is the vaccine that I want," said Dr. Marcus Plescia, chief medical officer of the Association of State and Territorial Health Officials.

Trending News Trending News More
  • California Governor Newsom signs $600 stimulus check bill
  • House to vote on $1.9 trillion COVID relief bill this week
  • Eager for a stimulus check? Early tax filing might help
  • Ex-officials trade blame for botched response to Capitol attack
  • Watch Live: Biden and Trudeau meet virtually and make statements

While the vaccine is logistically simpler, states could face hurdles in deciding which sites should be prioritized for the sturdier doses or how to handle residents hoping to obtain one vaccine over another. Some of that guidance could come this weekend, after the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices meets to discuss Johnson & Johnson's version.

"I think there's this feeling in a lot of jurisdictions that it'd be great if this vaccine came with very specific recommendations of who should get it and how to use it," said Plescia.

States also still don't know how many Johnson & Johnson doses they should expect. The Biden administration anticipates being able to allocate 2 million doses next week to jurisdictions. 

Both Johnson & Johnson and federal officials have acknowledged for weeks that the company faced obstacles as it ramped up production in the U.S., prompting the administration to modify its vaccination goals.

Last year, states were given specific allocations of both Pfizer and Moderna's vaccine weeks ahead of the FDA's authorization.

"We are planning to be ready when EUA is approved. It is not about getting in front of EUA, it's just making sure that we have everything locked so when EUA decision comes, distribution to the America people becomes immediate within 24 hours," General Gus Perna, head of the Trump administration's vaccine distribution effort, told reporters last year.

By comparison, before this week Biden administration officials had declined to provide a specific number of doses they expected from Johnson & Johnson, much less what allocations the states should expect. Asked if some of the doses would be set aside for pharmacies or other federal programs, the administration said Monday only that it's waiting to finalize its strategy after the FDA and CDC weigh in.

"Once we understand what the scientific community has to say, we will then be in a position to answer, I think, the very relevant questions that we need scientists' advice on," said White House senior adviser Andy Slavitt.

News Source: CBS News

Tags: search emergency use authorization vaccine biden administration pfizer and moderna the administration million doses end of february stimulus check trending news should expect a single dose dose vaccine to be ready the company the vaccine

Richard Holzer sentenced to nearly 20 years in plot to bomb Colorado synagogue

Next News:

Pennsylvania Dept. Of Education Allows Schools To Delay Standardized Testing Until Fall

By: KDKA-TV News Staff

HARRISBURG (KDKA) — The Pennsylvania Department of Education announced Saturday that the state will allow schools to delay standardized testing until the fall.

READ MORE: Republican West Virginia Governor Jim Justice Says Go Big Or Go Home On Stimulus

The Acting Education Secretary Noe Ortega has sent a letter to the U.S. Department of Education, giving Pennsylvania schools the option to delay federally-required academic achievement and English learner proficiency tests.

READ MORE: Pittsburgh Weather: Weekend Rain Showers, Chances Of Flooding

“Since the start of this pandemic, our work has been centered on protecting the health and safety of students, educators, and school staff across the state,” said Acting Secretary of Education Noe Ortega. “Our decision to extend the testing window continues to prioritize their health and safety and creates needed flexibilities for our unique school communities.”

Schools have the option of administering tests either in the spring or the fall to comply with federal guidelines, according to the state Department of Education.

MORE NEWS: U.S. House Passes COVID-19 Relief Bill That Would Provide Billions Of Dollars Of Support For Western Pa.

Stay with KDKA as we follow this developing story.

Other News

  • FDA Grants Emergency Approval To Single-Dose Johnson Johnson COVID-19 Vaccine
  • FDA authorizes Johnson & Johnson’s one-dose COVID-19 vaccine, boosting supplies and convenience
  • 2 Skiers Defy Death in Descent of Yosemites Half Dome
  • FDA Approves Emergency Use of Johnson Johnsons Covid-19 Vaccine
  • United States Authorizes Johnson Johnson Vaccine Against COVID-19 – Latest News, Breaking News, Top News Headlines
  • Most summer classes in Montgomery College to stay online, some in-person during fall semester
  • More than 70MILLION doses of vaccine have been administered in the US - with approval of Johnson & Johnson single shot adding another 20 million more before the end of March
  • New York : Review: Super Mario 3D World + Bowsers Fury, The Medium, Gods Will Fall and Scott Pilgrim vs. The World: The Game Complete Edition
  • US authorizes Johnson Johnson vaccine for COVID-19
  • U.S. Authorizes Johnson & Johnson's COVID-19 Vaccine
  • J&J’s 1-Dose Shot Cleared, Giving US 3rd COVID-19 Vaccine
  • JJs 1-dose shot cleared, giving US 3rd COVID-19 vaccine
  • The Best Street Style at Milan Fashion Week Fall 2021
  • Missouri State Expects Fall Semester to Be 'Close to Normal'
  • Four People Planning to Fish Fall Through Ice; One Drowns
  • Two men become first skiers to descend Yosemite’s Half Dome
  • check out the new graphics in this month’s update – Latest News, Breaking News, Top News Headlines
  • Skiers Defy Death In Descent Of Yosemites Half Dome
  • Pfizer to test Covid vaccine on children aged five to 11, boss reveals